000 | 01885 a2200613 4500 | ||
---|---|---|---|
005 | 20250517071820.0 | ||
264 | 0 | _c20170613 | |
008 | 201706s 0 0 eng d | ||
022 | _a1365-2133 | ||
024 | 7 |
_a10.1111/bjd.14367 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHunzelmann, N | |
245 | 0 | 0 |
_aThe Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies. _h[electronic resource] |
260 |
_bThe British journal of dermatology _cJun 2016 |
||
300 |
_a1384-7 p. _bdigital |
||
500 | _aPublication Type: Letter; Multicenter Study; Observational Study | ||
650 | 0 | 4 |
_aAntibodies, Antinuclear _xmetabolism |
650 | 0 | 4 |
_aDNA Topoisomerases, Type I _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFingers |
650 | 0 | 4 |
_aHand Dermatoses _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aScleroderma, Systemic _xcomplications |
650 | 0 | 4 |
_aSkin Ulcer _xetiology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aRiemekasten, G | |
700 | 1 | _aBecker, M O | |
700 | 1 | _aMoinzadeh, P | |
700 | 1 | _aKreuter, A | |
700 | 1 | _aMelchers, I | |
700 | 1 | _aMueller-Ladner, U | |
700 | 1 | _aMeier, F | |
700 | 1 | _aWorm, M | |
700 | 1 | _aLee, H | |
700 | 1 | _aHerrgott, I | |
700 | 1 | _aPfeiffer, C | |
700 | 1 | _aFierlbeck, G | |
700 | 1 | _aHenes, J | |
700 | 1 | _aJuche, A | |
700 | 1 | _aZeidler, G | |
700 | 1 | _aMensing, H | |
700 | 1 | _aGünther, C | |
700 | 1 | _aSárdy, M | |
700 | 1 | _aBurkhardt, H | |
700 | 1 | _aKoehm, M | |
700 | 1 | _aKuhr, K | |
700 | 1 | _aKrieg, T | |
700 | 1 | _aSunderkötter, C | |
773 | 0 |
_tThe British journal of dermatology _gvol. 174 _gno. 6 _gp. 1384-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.14367 _zAvailable from publisher's website |
999 |
_c25579583 _d25579583 |